| Literature DB >> 31908754 |
David N Kamber1, Sean S Nguyen1, Fang Liu2,3, Jeffrey S Briggs1, Hui-Wen Shih1, R David Row1, Zane G Long1, K N Houk2, Yong Liang3, Jennifer A Prescher1,4,5.
Abstract
Expanding the scope of bioorthogonal reactivity requires access to new and mutually compatible reagents. We report here that 1,2,4-triazines can be tuned to exhibit unique reaction profiles with biocompatible strained alkenes and alkynes. Computational analyses were used to identify candidate orthogonal reactions, and the predictions were experimentally verified. Notably, 5-substituted triazines, unlike their 6-substituted counterparts, undergo rapid [4 + 2] cycloadditions with a sterically encumbered strained alkyne. This unique, sterically controlled reactivity was exploited for dual bioorthogonal labeling. Mutually orthogonal triazines and cycloaddition chemistries will enable new multi-component imaging applications. This journal is © The Royal Society of Chemistry 2019.Entities:
Year: 2019 PMID: 31908754 PMCID: PMC6910137 DOI: 10.1039/c9sc01427f
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Inverse electron-demand Diels–Alder (IED-DA) reactions. (A) Triazine (X = CH) and tetrazine (X = N) scaffolds react with strained alkynes to form stable cycloadducts. (B) Isomeric 1,2,4-triazines and 1,2,4,5-tetrazines examined in this work.
DFT-computed activation free energies (kcal mol–1) and predicted rate constants (M–1 s–1) for tetrazine/triazine cycloadditions with strained dienophiles. Predicted rate constants (in water at 25 °C) range from 10–10 to 103. Red designates slow (10–10 to 10–4), yellow designates intermediate (10–3 to 10–2), and green designates fast (10–2 to 103) rates
|
|
Second order rate constants (M–1 s–1) for tetrazine and triazine cycloadditions with strained dienophiles. All reactions were conducted at 25 °C and monitored via1H-NMR spectroscopy. Reactions were run in CD3CN containing 10–50% d-PBS unless otherwise stated. N.R. indicates no reaction after 24 h and a corresponding rate constant (k2) < 10–4 M–1 s–1. The color code is defined in Table 1
|
|
Rate determined in ref. 18.
Reactions were run in 40% CD3OD in CD3CN.
Rate not determined. After 24 h, 15% conversion to an unisolable product was observed.
Rate determined in ref. 12.
The rate constant as measured with unsubstituted TCO in ref. 20.
Fig. 2Isomeric triazines exhibit unique bioorthogonal reactivities. (A) 5-Phenyl-triazine (2) reacts exclusively with TMTH. The reaction was monitored by 1H-NMR spectroscopy (top). The plot of reaction progress over time is shown below. (B) 5-Phenyl-1,2,4-triazine (2) can be used in combination with disubstituted tetrazine and cyclopropene scaffolds. The reagents were combined and monitored by 1H-NMR spectroscopy (top). The plot of reaction progress over time is shown below.
Fig. 3Orthogonal [4 + 2] cycloadditions. All reagents (2.5 mM) were combined and the reactions were monitored by HPLC (210 nm). Two distinct cycloadducts were observed.
Fig. 4Distortion/interaction analysis of factors controlling mutually orthogonal cycloadditions. Black arrows are activation potential energies, green and blue arrows are distortion energies of dienophile and diene, respectively, and red arrows are interactions energies. All values are given in kcal mol–1.
Fig. 5Orthogonal [4 + 2] cycloadditions enable dual protein labeling. (A) Nluc-Triazine and GFP-Cp were mixed 1 : 1 in PBS (pH 7.3, 2 μM), and subsequently treated with TMTH (9) and tetrazine 3 (1 mM). (B) Quantitative conversion to the expected cycloadducts was observed after 3 h via mass spectrometry. N-Terminal methionine cleavage (–Met) was observed for both proteins and their respective cycloadducts.